FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899542993> ?p ?o ?g. }

• W2899542993 abstract "BACKGROUND CONTEXT Following spine surgery, most patients receive opioid medication for analgesia. Opioids have caused controversy in popular culture because of frequent overuse and negative side effects. Given the current opioid epidemic, alternative postoperative analgesic strategies are being explored. The endocannabinoid system, a known regulator of pain reception, has been shown to have anti-nociceptive activity in animal models of acute tissue and nerve injury. Likewise, endocannabinoids are important to bone homeostasis via activity at CB1 and CB2 receptors; increasing numbers of osteoblasts and limiting the development of osteoporosis. Like the FDA approved synthetic cannabinoid agonists currently used to treat cancer pain, WIN55.212-2 (WIN55) acts as a dual agonist at both CB1 and CB2 receptors. Our in vitro work has demonstrated that WIN55 has no negative effect on the osteogenic differentiation capacity of rat bone marrow stem cells (BMSC). Hence, WIN55 was examined as a postoperative pain analgesic in rats following posterolateral spinal fusion. PURPOSE To determine whether the dual cannabinoid receptor agonist, WIN55.212-2, has a quantifiable effect on spinal fusion when used for postoperative analgesia. METHODS Sprague Dawley rat BMSC was cultured under osteogenic conditions and treated with WIN55. Alkaline phosphatase (ALP) activity assay, matrix mineralization assay, and qPCR were performed. Forty-five female Sprague Dawley rats underwent L4-L5 PLF with placement of acellular-collagen sponge loaded with 1ug of recombinant bone morphogenetic protein-2. Experimental groups received either low dose (0.5mg/kg, n=15) or high dose (2.5mg/kg, n=15) WIN55, delivered postoperatively for 5 days via intraperitoneal injection. A control group (n=15) received intraperitoneal DMSO for 5 days postoperatively. All animals received routine intra-and postoperative pain control per protocol. Spine fusion was assessed using radiography, manual palpation-based fusion scoring, and microCT. For fusion scoring, an established scoring system was used whereby spines with an average score ≥1 were considered fused. RESULTS Early and late markers of osteogenic differentiation, ALP activity, and mineralization, were not inhibited by treatment of WIN55. mRNA expression of Alp and Run×2 was similar between DMSO and WIN55 treated cells. Rats treated with low dose WIN55 demonstrated the most robust fusion rate (93%) and mean fusion score (1.69). The high dose group had a fusion rate of 73% and a mean fusion score of 1.43. DMSO controls had the lowest fusion rate (60%) and score (1.17). The low dose group had a significantly greater fusion rate and mean score than the control group (pl0.05, pl0.05). No significant differences in fusion existed between the low dose and high dose groups. CONCLUSIONS The opioid crisis has prompted strong interest in the development of alternative strategies for pain management after spine procedures. However, clear evidence that alternative treatments have no negative impact on bone healing is necessary before consideration of their use. We have presented preclinical evidence that WIN55, a dual cannabinoid receptor agonist, does not adversely affect spinal fusion in a rat model. These results support the notion that cannabinoid receptor agonists may be used for postoperative analgesia following spine surgeries without risk of inhibiting bone healing. Continued analysis of microCT imaging will allow us to further quantify the effects of WIN55 on new bone growth." @default.
• W2899542993 created "2018-11-16" @default.
• W2899542993 creator A5002282417 @default.
• W2899542993 creator A5031268844 @default.
• W2899542993 creator A5031463166 @default.
• W2899542993 creator A5058182665 @default.
• W2899542993 creator A5059535875 @default.
• W2899542993 creator A5065632850 @default.
• W2899542993 creator A5071737675 @default.
• W2899542993 creator A5079142915 @default.
• W2899542993 creator A5083376797 @default.
• W2899542993 date "2018-08-01" @default.
• W2899542993 modified "2023-09-24" @default.
• W2899542993 title "Friday, September 28, 2018 4:05 PM–5:05 PM abstracts: basic science of spinal fusion" @default.
• W2899542993 doi "https://doi.org/10.1016/j.spinee.2018.06.502" @default.
• W2899542993 hasPublicationYear "2018" @default.
• W2899542993 type Work @default.
• W2899542993 sameAs 2899542993 @default.
• W2899542993 citedByCount "0" @default.
• W2899542993 crossrefType "journal-article" @default.
• W2899542993 hasAuthorship W2899542993A5002282417 @default.
• W2899542993 hasAuthorship W2899542993A5031268844 @default.
• W2899542993 hasAuthorship W2899542993A5031463166 @default.
• W2899542993 hasAuthorship W2899542993A5058182665 @default.
• W2899542993 hasAuthorship W2899542993A5059535875 @default.
• W2899542993 hasAuthorship W2899542993A5065632850 @default.
• W2899542993 hasAuthorship W2899542993A5071737675 @default.
• W2899542993 hasAuthorship W2899542993A5079142915 @default.
• W2899542993 hasAuthorship W2899542993A5083376797 @default.
• W2899542993 hasConcept C126322002 @default.
• W2899542993 hasConcept C141071460 @default.
• W2899542993 hasConcept C148001335 @default.
• W2899542993 hasConcept C15490471 @default.
• W2899542993 hasConcept C170493617 @default.
• W2899542993 hasConcept C2778938600 @default.
• W2899542993 hasConcept C2780375110 @default.
• W2899542993 hasConcept C2780820201 @default.
• W2899542993 hasConcept C2781063702 @default.
• W2899542993 hasConcept C2910065304 @default.
• W2899542993 hasConcept C42219234 @default.
• W2899542993 hasConcept C71924100 @default.
• W2899542993 hasConcept C93248783 @default.
• W2899542993 hasConcept C98274493 @default.
• W2899542993 hasConceptScore W2899542993C126322002 @default.
• W2899542993 hasConceptScore W2899542993C141071460 @default.
• W2899542993 hasConceptScore W2899542993C148001335 @default.
• W2899542993 hasConceptScore W2899542993C15490471 @default.
• W2899542993 hasConceptScore W2899542993C170493617 @default.
• W2899542993 hasConceptScore W2899542993C2778938600 @default.
• W2899542993 hasConceptScore W2899542993C2780375110 @default.
• W2899542993 hasConceptScore W2899542993C2780820201 @default.
• W2899542993 hasConceptScore W2899542993C2781063702 @default.
• W2899542993 hasConceptScore W2899542993C2910065304 @default.
• W2899542993 hasConceptScore W2899542993C42219234 @default.
• W2899542993 hasConceptScore W2899542993C71924100 @default.
• W2899542993 hasConceptScore W2899542993C93248783 @default.
• W2899542993 hasConceptScore W2899542993C98274493 @default.
• W2899542993 hasLocation W28995429931 @default.
• W2899542993 hasOpenAccess W2899542993 @default.
• W2899542993 hasPrimaryLocation W28995429931 @default.
• W2899542993 hasRelatedWork W1489783725 @default.
• W2899542993 hasRelatedWork W1506200166 @default.
• W2899542993 hasRelatedWork W2039318446 @default.
• W2899542993 hasRelatedWork W2080531066 @default.
• W2899542993 hasRelatedWork W2148612803 @default.
• W2899542993 hasRelatedWork W2373994074 @default.
• W2899542993 hasRelatedWork W2748952813 @default.
• W2899542993 hasRelatedWork W2780146991 @default.
• W2899542993 hasRelatedWork W2899084033 @default.
• W2899542993 hasRelatedWork W3012411836 @default.
• W2899542993 isParatext "false" @default.
• W2899542993 isRetracted "false" @default.
• W2899542993 magId "2899542993" @default.
• W2899542993 workType "article" @default.